nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—oviduct—ovarian cancer	0.113	0.2	CbGeAlD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—ANXA3—ovarian cancer	0.0626	0.15	CbGpPWpGaD
Amcinonide—ANXA1—myometrium—ovarian cancer	0.0361	0.064	CbGeAlD
Amcinonide—ANXA1—embryo—ovarian cancer	0.0347	0.0616	CbGeAlD
Amcinonide—ANXA1—epithelium—ovarian cancer	0.0283	0.0502	CbGeAlD
Amcinonide—ANXA1—uterine cervix—ovarian cancer	0.0281	0.0498	CbGeAlD
Amcinonide—ANXA1—decidua—ovarian cancer	0.0267	0.0475	CbGeAlD
Amcinonide—ANXA1—endometrium—ovarian cancer	0.0254	0.0451	CbGeAlD
Amcinonide—ANXA1—gonad—ovarian cancer	0.0236	0.0418	CbGeAlD
Amcinonide—ANXA1—uterus—ovarian cancer	0.0234	0.0415	CbGeAlD
Amcinonide—ANXA1—female reproductive system—ovarian cancer	0.021	0.0373	CbGeAlD
Amcinonide—ANXA1—bone marrow—ovarian cancer	0.0199	0.0352	CbGeAlD
Amcinonide—ANXA1—female gonad—ovarian cancer	0.0191	0.034	CbGeAlD
Amcinonide—ANXA1—vagina—ovarian cancer	0.019	0.0338	CbGeAlD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—SPDEF—ovarian cancer	0.0181	0.0433	CbGpPWpGaD
Amcinonide—ANXA1—testis—ovarian cancer	0.017	0.0301	CbGeAlD
Amcinonide—NR3C1—myometrium—ovarian cancer	0.0125	0.0222	CbGeAlD
Amcinonide—ANXA1—lymph node—ovarian cancer	0.0123	0.0218	CbGeAlD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.0121	0.0289	CbGpPWpGaD
Amcinonide—NR3C1—embryo—ovarian cancer	0.0121	0.0214	CbGeAlD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.0113	0.0269	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—NR5A1—ovarian cancer	0.0109	0.0259	CbGpPWpGaD
Amcinonide—NR3C1—epithelium—ovarian cancer	0.00984	0.0175	CbGeAlD
Amcinonide—NR3C1—uterine cervix—ovarian cancer	0.00975	0.0173	CbGeAlD
Amcinonide—NR3C1—decidua—ovarian cancer	0.00929	0.0165	CbGeAlD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.00918	0.0219	CbGpPWpGaD
Amcinonide—NR3C1—endometrium—ovarian cancer	0.00882	0.0157	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00858	0.0205	CbGpPWpGaD
Amcinonide—NR3C1—gonad—ovarian cancer	0.00818	0.0145	CbGeAlD
Amcinonide—NR3C1—uterus—ovarian cancer	0.00813	0.0144	CbGeAlD
Amcinonide—NR3C1—female reproductive system—ovarian cancer	0.00731	0.013	CbGeAlD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—ovarian cancer	0.00699	0.0167	CbGpPWpGaD
Amcinonide—NR3C1—bone marrow—ovarian cancer	0.0069	0.0122	CbGeAlD
Amcinonide—NR3C1—female gonad—ovarian cancer	0.00665	0.0118	CbGeAlD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.00664	0.0158	CbGpPWpGaD
Amcinonide—NR3C1—vagina—ovarian cancer	0.00661	0.0117	CbGeAlD
Amcinonide—ANXA1—Spinal Cord Injury—GADD45A—ovarian cancer	0.00645	0.0154	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.0062	0.0148	CbGpPWpGaD
Amcinonide—NR3C1—testis—ovarian cancer	0.0059	0.0105	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptors—PGR—ovarian cancer	0.00541	0.0129	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.0053	0.0126	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—HNF1B—ovarian cancer	0.00502	0.012	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.00484	0.0116	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.00453	0.0108	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.00439	0.0105	CbGpPWpGaD
Amcinonide—NR3C1—lymph node—ovarian cancer	0.00427	0.00758	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00427	0.0102	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.0041	0.00979	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.00401	0.00957	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—ATF3—ovarian cancer	0.00385	0.0092	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TLR4—ovarian cancer	0.00379	0.00904	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.00376	0.00897	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—PGR—ovarian cancer	0.0035	0.198	CrCbGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.00343	0.00818	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.0034	0.00811	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.00329	0.00786	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.00329	0.00786	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.00323	0.00772	CbGpPWpGaD
Amcinonide—Betamethasone—PGR—ovarian cancer	0.0032	0.181	CrCbGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—ovarian cancer	0.00319	0.00763	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—RBL2—ovarian cancer	0.00317	0.00756	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.00303	0.00723	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—ESR1—ovarian cancer	0.00289	0.00689	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—ovarian cancer	0.00289	0.00689	CbGpPWpGaD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—ovarian cancer	0.00269	0.00642	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.00263	0.00629	CbGpPWpGaD
Amcinonide—Fluoxymesterone—ESR1—ovarian cancer	0.0026	0.147	CrCbGaD
Amcinonide—ANXA1—Spinal Cord Injury—CXCL8—ovarian cancer	0.00257	0.00613	CbGpPWpGaD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—ovarian cancer	0.00256	0.00611	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.00251	0.00599	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CDKN1B—ovarian cancer	0.00251	0.00599	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CASP3—ovarian cancer	0.00246	0.00587	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL2—ovarian cancer	0.00245	0.00586	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HSD17B6—ovarian cancer	0.00242	0.00578	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CCND1—ovarian cancer	0.00239	0.00571	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.00237	0.00566	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MMP9—ovarian cancer	0.00232	0.00555	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.00228	0.00545	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	0.00225	0.00536	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.00219	0.00524	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DLC1—ovarian cancer	0.00206	0.00492	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.00202	0.00482	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MAPK3—ovarian cancer	0.00197	0.00471	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.00196	0.00469	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.00194	0.00464	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MYC—ovarian cancer	0.00192	0.00458	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.0019	0.00453	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—GADD45A—ovarian cancer	0.00189	0.0045	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MAPK1—ovarian cancer	0.00188	0.00448	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—EGFR—ovarian cancer	0.00188	0.00448	CbGpPWpGaD
Amcinonide—Dexamethasone—PGR—ovarian cancer	0.00186	0.106	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.00184	0.0044	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—ESR1—ovarian cancer	0.00177	0.00423	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL8—ovarian cancer	0.00175	0.00419	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—ovarian cancer	0.00175	0.00417	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP1B1—ovarian cancer	0.00174	0.0987	CrCbGaD
Amcinonide—NR3C1—Endoderm Differentiation—APC—ovarian cancer	0.00171	0.00409	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.00171	0.00409	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.00171	0.00407	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BCL9—ovarian cancer	0.00168	0.00401	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.00167	0.00399	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.00163	0.00389	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.00161	0.00385	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—ovarian cancer	0.00158	0.00376	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.00158	0.00376	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.00158	0.00376	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.00157	0.00375	CbGpPWpGaD
Amcinonide—Fluticasone furoate—ABCB1—ovarian cancer	0.00156	0.0884	CrCbGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.00154	0.00368	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.00154	0.00368	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NR5A1—ovarian cancer	0.00148	0.00354	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL8—ovarian cancer	0.00148	0.00353	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.00146	0.00348	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—ovarian cancer	0.00144	0.00344	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.00142	0.00339	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.00134	0.0032	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DOK1—ovarian cancer	0.00133	0.00317	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.00131	0.00312	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.00129	0.00309	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.00128	0.00305	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.00128	0.00305	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	0.00127	0.00304	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PPP1CC—ovarian cancer	0.00125	0.00298	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—ovarian cancer	0.00123	0.00294	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	0.00122	0.00292	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.00121	0.00288	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN1B—ovarian cancer	0.0012	0.00287	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL2—ovarian cancer	0.00118	0.00281	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.00118	0.00281	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—CTNNB1—ovarian cancer	0.00116	0.00278	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	0.00116	0.00277	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	0.00116	0.00277	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCND1—ovarian cancer	0.00115	0.00274	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.00114	0.00271	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—PIK3CA—ovarian cancer	0.00113	0.00269	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—ovarian cancer	0.00111	0.00266	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PTEN—ovarian cancer	0.00111	0.00265	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.00111	0.00265	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	0.0011	0.00262	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.00109	0.00261	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—ovarian cancer	0.00109	0.00259	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.00107	0.00256	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6ST—ovarian cancer	0.00106	0.00253	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—ovarian cancer	0.00104	0.00248	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	0.00101	0.00241	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—WDR77—ovarian cancer	0.001	0.00239	CbGpPWpGaD
Amcinonide—Prednisone—ABCB1—ovarian cancer	0.000952	0.0539	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—HDAC6—ovarian cancer	0.000946	0.00226	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000933	0.00223	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	0.000933	0.00223	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000926	0.00221	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—ovarian cancer	0.000921	0.0022	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000905	0.00216	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—ovarian cancer	0.000896	0.00214	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	0.000893	0.00213	CbGpPWpGaD
Amcinonide—Prednisolone—ABCB1—ovarian cancer	0.000877	0.0497	CrCbGaD
Amcinonide—Betamethasone—ABCB1—ovarian cancer	0.00086	0.0487	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—YAP1—ovarian cancer	0.000845	0.00202	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—YAP1—ovarian cancer	0.000837	0.002	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—ovarian cancer	0.000834	0.00199	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—XIAP—ovarian cancer	0.00082	0.00196	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000819	0.00196	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SMARCA4—ovarian cancer	0.000799	0.00191	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—ovarian cancer	0.000794	0.0019	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TTF1—ovarian cancer	0.000786	0.00188	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EREG—ovarian cancer	0.00078	0.00186	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—ovarian cancer	0.000756	0.00181	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PGR—ovarian cancer	0.000738	0.00176	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PGR—ovarian cancer	0.000731	0.00175	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NR5A1—ovarian cancer	0.000713	0.0017	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—CTNNB1—ovarian cancer	0.000693	0.00165	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—ovarian cancer	0.000692	0.00165	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000688	0.00164	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PARP1—ovarian cancer	0.000686	0.00164	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PARP1—ovarian cancer	0.000679	0.00162	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—ovarian cancer	0.000666	0.00159	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6ST—ovarian cancer	0.00065	0.00155	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000649	0.00155	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CG—ovarian cancer	0.000624	0.00149	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000621	0.00148	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—ovarian cancer	0.00061	0.00146	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000605	0.00144	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—STAT3—ovarian cancer	0.000604	0.00144	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000599	0.00143	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	0.000568	0.00136	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	0.000563	0.00134	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PPP2R1A—ovarian cancer	0.000551	0.00132	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CD—ovarian cancer	0.000549	0.00131	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000527	0.00126	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000527	0.00126	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—ovarian cancer	0.000506	0.00121	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCB1—ovarian cancer	0.0005	0.0283	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL2—ovarian cancer	0.000484	0.00116	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CB—ovarian cancer	0.000478	0.00114	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—ovarian cancer	0.00046	0.0011	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL2—ovarian cancer	0.000439	0.00105	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TERT—ovarian cancer	0.000438	0.00105	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—ovarian cancer	0.000422	0.00101	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—YAP1—ovarian cancer	0.000407	0.000971	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CAV1—ovarian cancer	0.000405	0.000967	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR1—ovarian cancer	0.000394	0.000941	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ESR1—ovarian cancer	0.00039	0.000932	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6ST—ovarian cancer	0.000384	0.000917	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APC—ovarian cancer	0.000369	0.000881	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CG—ovarian cancer	0.000369	0.000881	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NRAS—ovarian cancer	0.000369	0.000881	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000365	0.000871	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PGR—ovarian cancer	0.000355	0.000848	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK3—ovarian cancer	0.000353	0.000844	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK1—ovarian cancer	0.000336	0.000803	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—ovarian cancer	0.000336	0.000803	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PARP1—ovarian cancer	0.00033	0.000789	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CD—ovarian cancer	0.000324	0.000774	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000321	0.000767	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—ovarian cancer	0.000317	0.000758	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CA—ovarian cancer	0.000292	0.000697	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB2—ovarian cancer	0.000286	0.000684	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MTOR—ovarian cancer	0.000283	0.000675	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CB—ovarian cancer	0.000283	0.000675	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—ovarian cancer	0.000272	0.000649	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRAS—ovarian cancer	0.00027	0.000644	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPP2R1A—ovarian cancer	0.000268	0.00064	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1B—ovarian cancer	0.000265	0.000633	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—ovarian cancer	0.000262	0.000627	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—ovarian cancer	0.00026	0.000621	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL2—ovarian cancer	0.00026	0.00062	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—ovarian cancer	0.000258	0.000617	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCND1—ovarian cancer	0.000253	0.000604	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CTNNB1—ovarian cancer	0.000251	0.000598	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—ovarian cancer	0.000246	0.000587	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTEN—ovarian cancer	0.000244	0.000583	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—ovarian cancer	0.000238	0.000569	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—ovarian cancer	0.000221	0.000527	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT3—ovarian cancer	0.000218	0.000522	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRAS—ovarian cancer	0.000218	0.00052	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK3—ovarian cancer	0.000209	0.000498	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—ovarian cancer	0.000205	0.000489	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—ovarian cancer	0.000203	0.000485	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK1—ovarian cancer	0.000199	0.000474	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—ovarian cancer	0.000199	0.000474	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR1—ovarian cancer	0.00019	0.000453	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—ovarian cancer	0.000188	0.000448	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CA—ovarian cancer	0.000172	0.000411	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—ovarian cancer	0.000167	0.000398	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRAS—ovarian cancer	0.000159	0.000381	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—ovarian cancer	0.000153	0.000364	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—ovarian cancer	0.000141	0.000336	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MAPK3—ovarian cancer	0.000101	0.000242	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—ovarian cancer	9.87e-05	0.000236	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—ovarian cancer	6.84e-05	0.000163	CbGpPWpGaD
